1. Mutation Status and Immunohistochemical Correlation of KRAS, NRAS, and BRAF in 260 Chinese Colorectal and Gastric Cancers
   Qiwei Yang et al, 2018, Frontiers in Oncology CrossRef
2. Deficient mismatch repair and RAS mutation in colorectal carcinoma patients: a retrospective study in Eastern China
   Xiangyan Zhang et al, 2018, PeerJ CrossRef
3. Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer
   Chengfeng Wang et al, 2022, Journal of Clinical Laboratory Analysis CrossRef
4. Somatic BRAF V600E Mutation in Familial Colorectal Cancer Type X: A New Study in Central Iran
   Mehrdad Zeinalian et al, 2021, Jentashapir Journal of Cellular and Molecular Biology CrossRef
5. KRAS, NRAS, BRAF, HER2 and microsatellite instability in metastatic colorectal cancer – practical implications for the clinician
   Vlad-Adrian Afrăsânie et al, 2019, Radiology and Oncology CrossRef
6. The possibilities of therapy of patients with metastatic colorectal cancer with BRAF V600E mutation. Clinical cases
   Elizaveta M. Polyanskaya et al, 2023, Journal of Modern Oncology CrossRef
7. Clinical significance of the BRAFV600E mutation in Asian patients with colorectal cancer
   Hou-Hsuan Cheng et al, 2018, International Journal of Colorectal Disease CrossRef
8. Clinical Impact and Prognostic Role of KRAS/BRAF/PIK3CA Mutations in Stage I Colorectal Cancer
   Luca Reggiani Bonetti et al, 2018, Disease Markers CrossRef
9. Immunohistochemical Expression of Dual-Specificity Protein Phosphatase 4 in Patients with Colorectal Adenocarcinoma
   Jongmin Sim et al, 2015, Gastroenterology Research and Practice CrossRef
10. KRASandBRAFgene mutations and DNA mismatch repair status in Chinese colorectal carcinoma patients
    Ju-Xiang Ye, 2015, World Journal of Gastroenterology CrossRef
11. BRAF Gene Mutation Analysis in Colorectal Cancer in South of Iran
    Farshid Javadi et al, 2014, Annals of Colorectal Research CrossRef
12. Mutation status and prognostic values of KRAS, NRAS, BRAF and PIK3CA in 353 Chinese colorectal cancer patients
    Fang Guo et al, 2018, Scientific Reports CrossRef
13. Frequency and Clinicopathological Characteristics of Patients With KRAS/BRAF Double-Mutant Colorectal Cancer: An In Silico Study
    Shiro Uchida et al, 2022, Pathology and Oncology Research CrossRef
14. FOLFOXIRI versus FOLFOX or FOLFIRI with targeted therapy in patients with mutant BRAF metastatic colorectal cancer: A systematic review and meta-analysis
    M. Yu. Fedyanin et al, 2020, Meditsinskiy sovet = Medical Council CrossRef